Public transactions advised by JK Capital

Issuance of a Commercial Note by Grupo Cartão de Todos, in the amount of R$82.5 million.

JK Capital acted as exclusive financial advisor to Grupo Cartão de Todos.

Grupo Fleury (FLRY3) acquired 100% of Confiance.

JK Capital acted as exclusive financial advisor to Confiance.

Vision One acquired 100% of Centro de Oftalmologia Avançada (COA).

JK Capital acted as exclusive financial advisor to COA.

Vision One acquired Hospital de Olhos de Florianópolis (HOF).

JK Capital acted as exclusive financial advisor to HOF.

Care Plus completed the acquisition of Inpao Dental.

JK Capital acted as exclusive financial advisor to Inpao Dental.

Vision One acquired Laser Ocular ABC.

JK Capital acted as exclusive financial advisor to Laser Ocular ABC.

Vision One acquired Oftalmos Hospital da Visão.

JK Capital acted as exclusive financial advisor to Oftalmos.

GEF Capital Partners acquired a minority stake in Clean Medical.

JK Capital acted as exclusive financial advisor to Clean Medical.

Unity acquired a majority stake in Ressonance.

JK Capital acted as exclusive financial advisor to Ressonance.

NotreDame Intermédica (GNDI3) acquired Hospital do Coração de Londrina.

JK Capital acted as exclusive financial advisor to Hospital do Coração de Londrina.

Hospital Care, a portfolio company of private equity fund Crescera Investimentos and Abaporu fund, acquired a 60% stake in Grupo Austa.

JK Capital acted as exclusive financial advisor to Grupo Austa.

Grupo Hapvida acquired Grupo São José.

JK Capital acted as exclusive financial advisor to Grupo São José.

H.Hemo acquired Serviço de Hematologia e Hemoterapia.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired STS.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired Hemovida.

JK Capital acted as exclusive financial advisor to H.Hemo.

Premium acquired Auri Medicina Diagnóstica.

JK Capital acted as exclusive financial advisor to Auri Medicina Diagnóstica.

Sanphar, a company belonging to the Austrian group ERBER Group, acquired 100% of IPEVE.

JK Capital acted as exclusive financial advisor to Sanphar / ERBER Group.

H.Hemo acquired CTA.

JK Capital acted as exclusive financial advisor to H.Hemo.

Proparco made a capital investment in H.Hemo.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired Hemovalle.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired IHHC.

JK Capital acted as exclusive financial advisor to H.Hemo.

Ghelfond acquired Ecoimagem.

JK Capital acted as exclusive financial advisor to Ecoimagem.

H.Hemo acquired a 51% stake in Unihemo.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired a 60.7% stake in Hemomed.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired a 51% stake in Hemoservice.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired a 51% stake in Hemoclínica.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired a 51% stake in Criobanco.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired CHCM.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired a 51% stake in SHSM.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired Hemoclínica.

JK Capital acted as exclusive financial advisor to H.Hemo.

H.Hemo acquired Fujisan.

JK Capital acted as exclusive financial advisor to H.Hemo.

Unique acquired a majority stake in Ultra-X.

JK Capital acted as exclusive financial advisor to Ultra-X.

H.Hemo acquired Bioclínica.

JK Capital acted as exclusive financial advisor to H.Hemo.

2bCapital made a capital investment in H.Hemo.

JK Capital acted as exclusive financial advisor to H.Hemo.

Debt issuance in the amount of R$15 million.

JK Capital acted as exclusive financial advisor to H.Hemo.

SIS Group acquired Vivace.

JK Capital acted as exclusive financial advisor to Vivace.

Grupo Fleury (FLRY3) acquired Serdil.

JK Capital acted as exclusive financial advisor to Serdil.

Ghelfond Diagnósticos acquired a majority stake in Grupo IMEDI.

JK Capital acted as exclusive financial advisor to Grupo IMEDI.

Advised on a process for admitting new partners to Centro Diagnóstico por Imagem de Barretos.

Advised on the shareholder restructuring among the partners of WM Diagnósticos por Imagem.

Issuance of a Bank Credit Certificate.

JK Capital acted as exclusive financial advisor to Ecoimagem.